This site is intended for healthcare professionals
  • Home
  • /
  • News & Insights
  • /
  • 2020
  • /
  • 05
  • /
  • Phase III ASPEN trial of Brukinsa in Waldenström’s...
News

Phase III ASPEN trial of Brukinsa in Waldenström’s macroglobulinemia shows positive follow-up data.- BeiGene

Read time: 2 mins
Last updated:16th Mar 2021
Published:31st May 2020
Condition: Waldenstrom's Macroglobulinemia
Type: drug
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest